Moderna Inc.'s undefined said Thursday that its COVID-19 vaccine is 93% efficacious six months after the second dose as part of its second-quarter earnings...
Moderna Inc.'s MRNA, +8.42% said Thursday that its COVID-19 vaccine is 93% efficacious six months after the second dose as part of its second-quarter earnings announcement. This is different than what Pfizer Inc. PFE, -1.07% said last week about its COVID-19 shot, which is that immunity can wane to 83.7% four to six months after getting the second shot.
Both vaccines are two-dose mRNA shots that had an efficacy rate of about 95% in clinical trials."We are pleased that our COVID-19 vaccine is showing durable efficacy of 93% through six months," Moderna CEO Stéphane Bancel said in a statement. The figure came from a new analysis of the Phase 3 clinical trial it conducted in the U.S. At that time, Moderna said the vaccine had an efficacy rate of 94.1%. Moderna's stock is up 301.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Delta variant now accounts for more than 93% of Covid-19 cases in the USThe Delta variant continues to accelerate its spread across the US, even as the Biden administration and CDC continue their push to get Americans vaccinated. Follow here for the latest news.
Read more »
COVID-19 live updates: Delta variant now 93% of all sequenced cases in US'Family members...would lay down their life to protect one of their siblings or their child...yet, you have all these people not willing to step in front of a vaccination shot.' A respiratory therapist on why the 'vaccine is something worth getting.'
Read more »
Covid-19: One more Covid-linked death and 1,040 new casesThe total number of Covid-19 vaccines administered in Northern Ireland is now 2,284,540.
Read more »
Covid-19: Scotland to end most Covid rules and cabinet splits over travelFive things you need to know about the coronavirus pandemic this Tuesday evening.
Read more »
Pfizer, Moderna Raise Prices Of Covid-19 Coronavirus Vaccines For European UnionThe EU has now surpassed the U.S. in getting its population vaccinated. But will higher Covid-19 coronavirus vaccine prices derail this progress?
Read more »
Malaysia grants conditional approval for Moderna COVID-19 vaccineMalaysia's Health Ministry on Thursday said it has granted a conditional approval for the Moderna COVID-19 vaccine for emergency use.
Read more »